Furthermore, analyses of cell cycle-related proteins suggest that Corilagin arrested ovarian cancer cells in the G2/M phase by down-regulating the expression levels of Cyclin B1, Myt1, Phospho-Weel (p-Weel) and Phospho-cdc2 (p-cdc2) (Figure 4B). This evidence concerns the gene CCNB1 and ovarian cancer.